2026-09-05T00:41:46Zhttps://gredos.usal.es/oai/requestoai:gredos.usal.es:10366/1496832026-03-24T15:13:02Zcom_10366_149635com_10366_127837com_10366_4666com_10366_3823col_10366_149636
Gestión del Repositorio Documental de la Universidad de Salamanca
author
Remón Álvarez Arenas, María Mercedes
author
Morales Gama, Estefanía
author
Palomero Gil, María Rosario
2022-05-13T11:23:06Z
2022-05-13T11:23:06Z
2022-05-03
FarmaJournal, 7 (2022)
2445-1355
http://hdl.handle.net/10366/149683
The consumption of drugs indicated for the treatment of sleep disorders, anxiety and depression – benzodiazepines, Z analogues and antidepressants – has doubled in 2020 as a result of the global pandemic COVID-19 compared to 2019. The main objective of this study is to analyse the patients' profile treated with anxiolytics/antidepressants, taking into account their ages, sex, drugs taken and perseverance with medication. A cross-sectional descriptive observational study was designed, in which the study population consisted of patients being treated with at least one anxiolytic drug – hypnotic or benzodiazepine – with a total sample of 80 patients. Data collection was carried out from March to June at the chemist's by means of a questionnaire, answered voluntarily and anonymously by patients. A search by active ingredient/pharmaceutical speciality was carried out using drug technical sheets. The questionnaires were analysed with Python v3.8.5 database. It was observed that the consumption of this kind of drugs is more common among women, and among 20-30 year-old-people, being lorazepam the most dispensed anxiolytic and combined with antidepressants.
spa
info:eu-repo/semantics/openAccess
anxiety
pandemic
benzodiacepines
consumption
women
ansiedad
pandemia
benzodiacepinas
consumo
mujeres
Abordaje farmacoterapéutico de la ansiedad desde la oficina de farmacia
info:eu-repo/semantics/article
TG9zIGRlcmVjaG9zIGRlIGF1dG9yIGRlIGxvcyBkb2N1bWVudG9zIGRlcG9zaXRhZG9zIGVuIEdSRURPUyBlc3TDoW4gc29tZXRpZG9zIGEgbGEgbGVnaXNsYWNpw7NuIGVzcGHDsW9sYSByZWxhdGl2YSBhIGxhIHByb3BpZWRhZCBpbnRlbGVjdHVhbC4gTG9zIGF1dG9yZXMgZGUgbG9zIGRvY3VtZW50b3MgYWNjZXNpYmxlcyBkZXNkZSBlbCByZXBvc2l0b3JpbyBkb2N1bWVudGFsIGRlIGxhIFVTQUwgc29uIGxvcyDDum5pY29zIHF1ZSBvc3RlbnRhbiBkZXJlY2hvcyBzb2JyZSBzdXMgb2JyYXMsIGNvbiBsYXMgY2VzaW9uZXMgcXVlIGV2ZW50dWFsbWVudGUgaGF5YW4gcmVhbGl6YWRvIGEgdGVyY2Vyb3MuIExhIFVuaXZlcnNpZGFkIGRlIFNhbGFtYW5jYSBubyBwb3NlZSBkZXJlY2hvcyBkZSBwcm9waWVkYWQgaW50ZWxlY3R1YWwgc29icmUgbG9zIGRvY3VtZW50b3MgYWxvamFkb3MgZW4gR1JFRE9TLCBleGNlcHRvIHNvYnJlIGFxdWVsbG9zIHF1ZSBoYW4gc2lkbyBwcm9kdWNpZG9zIHBvciBsYSBtaXNtYS4KCkxhIGJhc2UgbGVnYWwgZGUgbG9zIGRlcmVjaG9zIGRlIGF1dG9yIGVuIEdSRURPUyBlcyBsYSBMZXkgMjMvMjAwNiwgZGUgNyBkZSBqdWxpbywgcG9yIGxhIHF1ZSBzZSBtb2RpZmljYSBlbCB0ZXh0byByZWZ1bmRpZG8gZGUgbGEgTGV5IGRlIFByb3BpZWRhZCBJbnRlbGVjdHVhbCwgYXByb2JhZG8gcG9yIGVsIFJlYWwgRGVjcmV0byBMZWdpc2xhdGl2byAxLzE5OTYsIGRlIDEyIGRlIGFicmlsIChCT0UgbsO6bWVybyAxNjIgZGUgOC83LzIwMDYpLCBxdWUgYXRyaWJ1eWUgYSBsb3MgYXV0b3JlcyBkZXJlY2hvcyBtb3JhbGVzIHkgZGVyZWNob3MgZGUgZXhwbG90YWNpw7NuLiBMb3MgZGVyZWNob3MgbW9yYWxlcyBzb24gaXJyZW51bmNpYWJsZXMgZSBpbmFsaWVuYWJsZXMsIG1pZW50cmFzIHF1ZSBsb3MgZGVyZWNob3MgZGUgZXhwbG90YWNpw7NuIHB1ZWRlbiBjZWRlcnNlIGEgdGVyY2Vyb3MuIExvcyBkZXJlY2hvcyBkZSBleHBsb3RhY2nDs24gYWZlY3RhbiBhIGxhIHJlcHJvZHVjY2nDs24sIGRpc3RyaWJ1Y2nDs24sIAoKY29tdW5pY2FjacOzbiBww7pibGljYSB5IHRyYW5zZm9ybWFjacOzbi4gU2kgZWwgYXV0b3IgaGEgY2VkaWRvIGFsZ3VubyBkZSBlc3RvcyBkZXJlY2hvcyBhIGVkaXRvcmVzIHUgb3RyYXMgZW50aWRhZGVzLCBzdXMgb2JyYXMgc29sbyBwb2Ryw61hbiBzZXIgZGVwb3NpdGFkYXMgZW4gdmlydHVkIGRlIGxhcyBjb25kaWNpb25lcyBhY29yZGFkYXMgZW4gbGEgY2VzacOzbiBkZSBkZXJlY2hvcyBkZSBhdXRvci4KCkdSRURPUyBlbXBsZWEgY29tbyBub3JtYXRpdmEgbGVnYWwgZGUgdXNvIHVuYSBMaWNlbmNpYSBDcmVhdGl2ZSBDb21tb25zLiBMYXMgbGljZW5jaWFzIGRlIHVzbyBpbmZvcm1hbiBkZSBsYXMgY29uZGljaW9uZXMgYmFqbyBsYXMgcXVlIHNlIGRpc3RyaWJ1eWUgdW5hIG9icmEgeSBzb2JyZSBjw7NtbyBsYSBtaXNtYSBzZSBwdWVkZSB1dGlsaXphci4gTGFzIGxpY2VuY2lhcyBkZSB1c28gYXJ0aWN1bGFuIGxhIGNlc2nDs24gcGFyY2lhbCBkZSBkZXJlY2hvcyBkZSBhdXRvciAoY29weWxlZnQpIGVuIHJlbGFjacOzbiBhIHN1cyBkZXJlY2hvcyBkZSBleHBsb3RhY2nDs24uIExvcyB1c3VhcmlvcyBxdWUgY29uc3VsdGVuIHVuYSBvYnJhIHN1amV0YSBhIGNvcHlsZWZ0IHNlIGNvbXByb21ldGVuIGEgcmVzcGV0YXIgc3UgbGljZW5jaWEgZGUgdXNvLiBMYXMgbGljZW5jaWFzIENyZWF0aXZlIENvbW1vbnMgcHJlc2VudGFuIGNvbmRpY2lvbmVzIGhvbW9nw6luZWFzIGVuIGxhIGNlc2nDs24gZGUgZGVyZWNob3MgZGUgYXV0b3IsIHRpZW5lbiB2YWxvciBub3JtYXRpdm8geSBzaXJ2ZW4gZGUgZm9ybWEgZWZlY3RpdmEgcGFyYSBsYSBwcm90ZWNjacOzbiBsZWdhbCBkZSBsYSBwcm9waWVkYWQgaW50ZWxlY3R1YWwuCgpQYXJhIHF1ZSBlbCBSZXBvc2l0b3JpbyBkZSBsYSBVbml2ZXJzaWRhZCBkZSBTYWxhbWFuY2EgcHVlZGEgcmVwcm9kdWNpciB5IGNvbXVuaWNhciBww7pibGljYW1lbnRlIHN1IGRvY3VtZW50byBlcyBuZWNlc2FyaW8gbGEgYWNlcHRhY2nDs24gZGUgdW5hIHNlcmllIGRlIHTDqXJtaW5vcy4gUG9yIGZhdm9yLCBsZWEgbGFzIHNpZ3VpZW50ZXMgY29uZGljaW9uZXMgZGUgbGljZW5jaWE6CgoxLkVtcGxlYW5kbyBlbCBzaXN0ZW1hIGRlIGF1dG9hcmNoaXZvIHVzdGVkIGFjZXB0YSBsYSBsaWNlbmNpYSBkZSB1c28gQ3JlYXRpdmUgQ29tbW9ucyBxdWUgYW1wYXJhIHRvZGEgbGEgZG9jdW1lbnRhY2nDs24gZGVwb3NpdGEgZW4gR3JlZG9zLCBxdWUgZXN0w6EgZGlzcG9uaWJsZSBlbiB0b2RhcyBsYXMgcMOhZ2luYXMgZGVsIHJlcG9zaXRvcmlvIGh0dHA6Ly9ncmVkb3MudXNhbC5lcy4KCjIuTGEgbGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyBkZSBHcmVkb3MgcGVybWl0ZSBhIGxhIFVuaXZlcnNpZGFkIGRlIFNhbGFtYW5jYSBsYSBkaWZ1c2nDs24gZGUgbG9zIGRvY3VtZW50b3MgZW52aWFkb3MsIG9ibGlnYSBhbCByZWNvbm9jaW1pZW50byBkZSBsYSBhdXRvcsOtYSBkZSBsb3MgZG9jdW1lbnRvcyBlIGltcGlkZSBsYSBjb21lcmNpYWxpemFjacOzbiBvIHRyYW5zZm9ybWFjacOzbiBkZSBsb3MgZG9jdW1lbnRvcyBzaW4gYXV0b3JpemFjacOzbiBleHByZXNhIGRlIGxvcyBhdXRvcmVzLgoKMy5FbCBhdXRvciBhY2VwdGEgcXVlIGxhIFVuaXZlcnNpZGFkIGRlIFNhbGFtYW5jYSBwdWVkYSBjb25zZXJ2YXIgbcOhcyBkZSB1bmEgY29waWEgZGUgZXN0ZSBkb2N1bWVudG8geSwgc2luIGFsdGVyYXIgc3UgY29udGVuaWRvLCBjb252ZXJ0aXJsbyBhIGN1YWxxdWllciBmb3JtYXRvIGRlIGZpY2hlcm8sIG1lZGlvIG8gc29wb3J0ZSwgcGFyYSBwcm9ww7NzaXRvcyBkZSBzZWd1cmlkYWQsIHByZXNlcnZhY2nDs24geSBhY2Nlc28uCgo0LkVsIGRlcG9zaXRhcmlvIGRlY2xhcmEgcXVlIGVsIGRvY3VtZW50byBlcyB1biB0cmFiYWpvIG9yaWdpbmFsIHN1eW8geS9vIHF1ZSB0aWVuZSBlbCBkZXJlY2hvIHBhcmEgb3RvcmdhciBsb3MgZGVyZWNob3MgY29udGVuaWRvcyBlbiBlc3RhIGxpY2VuY2lhLiBUYW1iacOpbiBkZWNsYXJhIHF1ZSBzdSBkb2N1bWVudG8gbm8gaW5mcmluZ2UsIGVuIHRhbnRvIGVuIGN1YW50byBsZSBzZWEgcG9zaWJsZSBzYWJlciwgbG9zIGRlcmVjaG9zIGRlIGF1dG9yIGRlIG5pbmd1bmEgb3RyYSBwZXJzb25hIG8gZW50aWRhZC4KCjUuU2kgZWwgZG9jdW1lbnRvIGNvbnRpZW5lIG1hdGVyaWFsZXMgZGUgbG9zIGN1YWxlcyBubyB0aWVuZSBsb3MgZGVyZWNob3MgZGUgYXV0b3IsIGRlY2xhcmEgcXVlIGhhIG9idGVuaWRvIGVsIHBlcm1pc28gc2luIHJlc3RyaWNjacOzbiBkZWwgcHJvcGlldGFyaW8gZGUgbG9zIGRlcmVjaG9zIGRlIGF1dG9yIHBhcmEgb3RvcmdhciBhIGxhIFVuaXZlcnNpZGFkIGRlIFNhbGFtYW5jYSBsb3MgZGVyZWNob3MgcmVxdWVyaWRvcyBwb3IgZXN0YSBsaWNlbmNpYSwgeSBxdWUgZXNlIG1hdGVyaWFsIGN1eW9zIGRlcmVjaG9zIHNvbiBkZSB0ZXJjZXJvcyBlc3TDoSBjbGFyYW1lbnRlIGlkZW50aWZpY2FkbyB5IHJlY29ub2NpZG8gZW4gZWwgdGV4dG8gbyBjb250ZW5pZG8gZGVsIGRvY3VtZW50byBlbnRyZWdhZG8uCgo2LlNpIGVsIGRvY3VtZW50byBzZSBiYXNhIGVuIHVuYSBvYnJhIHF1ZSBoYSBzaWRvIHBhdHJvY2luYWRhIG8gYXBveWFkYSBwb3IgdW5hIGFnZW5jaWEgdSBvcmdhbml6YWNpw7NuIGRpZmVyZW50ZSBkZSBsYSBVbml2ZXJzaWRhZCBkZSBTYWxhbWFuY2EsIHNlIHByZXN1cG9uZSBxdWUgc2UgaGEgY3VtcGxpZG8gY29uIGN1YWxxdWllciBkZXJlY2hvIGRlIHJldmlzacOzbiB1IG90cmFzIG9ibGlnYWNpb25lcyByZXF1ZXJpZGFzIHBvciBlc3RlIGNvbnRyYXRvIG8gYWN1ZXJkby4KCjcuTGEgVW5pdmVyc2lkYWQgZGUgU2FsYW1hbmNhIGlkZW50aWZpY2Fyw6EgY2xhcmFtZW50ZSBzdS9zIG5vbWJyZS9zIGNvbW8gZWwvbG9zIGF1dG9yL2VzIG8gcHJvcGlldGFyaW8vcyBkZSBsb3MgZGVyZWNob3MgZGVsIGRvY3VtZW50bywgeSBubyBoYXLDoSBuaW5ndW5hIGFsdGVyYWNpw7NuIGRlIHN1IGRvY3VtZW50byBkaWZlcmVudGUgYSBsYXMgcGVybWl0aWRhcyBlbiBlc3RhIGxpY2VuY2lhLg==
URL
https://gredos.usal.es/bitstream/10366/149683/1/Abordaje_farmacoterapeutico_de_la_ansied.pdf
File
MD5
5a11ced57f0d2ce40ad4cbda8710ff9c
320392
application/pdf
Abordaje_farmacoterapeutico_de_la_ansied.pdf
URL
https://gredos.usal.es/bitstream/10366/149683/5/Abordaje_farmacoterapeutico_de_la_ansied.pdf.txt
File
MD5
4f5ac62f0b67bf0dddf83ae9b7d02495
17338
text/plain
Abordaje_farmacoterapeutico_de_la_ansied.pdf.txt